Turndown for coronary artery bypass surgery: Never say never to revascularization

Area of Science:

• Cardiology
• Interventional Cardiology
• Cardiac Surgery

Background:

• Coronary artery disease management involves revascularization strategies like bypass surgery and stenting.
• Patients unsuitable for bypass surgery often require alternative treatments such as percutaneous coronary intervention (PCI).
• Distinguishing outcomes between acute coronary syndrome (ACS) and stable angina (SA) in this specific patient group is crucial.

Purpose of the Study:

• To compare the clinical outcomes of patients with ACS versus SA who were ineligible for bypass surgery and received coronary stenting.
• To evaluate the effectiveness and safety of coronary stenting as a revascularization strategy in high-risk patients.
• To identify potential differences in treatment pathways and results based on the underlying coronary syndrome.

Main Methods:

• Retrospective analysis of patient data from a single center.
• Comparison of baseline characteristics, procedural details, and clinical outcomes between ACS and SA cohorts.
• Inclusion of patients who were explicitly turned down for coronary artery bypass grafting (CABG) surgery.

Main Results:

• Patients with ACS generally presented with more severe symptoms and higher rates of comorbidities.
• Coronary stenting was successfully performed in both groups, but procedural complexities may differ.
• Early and late clinical outcomes, including major adverse cardiac events (MACE), were analyzed and compared between the ACS and SA groups.

Conclusions:

• Coronary stenting provides a viable revascularization option for carefully selected patients with ACS and SA who are not candidates for bypass surgery.
• Outcomes may vary between ACS and SA patients undergoing stenting, necessitating tailored management strategies.
• Further research is warranted to optimize treatment algorithms for these complex patient populations.